🟢 Cabaletta Bio is trading 10.44% up today after $128.2 million in warrant exercises

Cabaletta Bio is trading at $3.02, up +10.44%, after reporting approximately $128.2 million in aggregate gross proceeds from common-stock warrant exercises that expired September 12, 2026.

• The proceeds strengthen the company’s cash position.
• The announcement appears to be driving the September 14, 2026 advance.
• Major indexes were declining at midday, making the company-specific catalyst especially notable.